GMAB Genmab

Watchlist

20.800
-0.420-1.98%

Close Jan 17 16:00 ET

21.420
+0.620+2.98%

Post 20:01 ET

13.21BMarket Cap20.90P/E (TTM)

Genmab Key Stats

According to the latest financial report of Genmab, the latest earnings per share (TTM) for the company is 1.98. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: DKK

Quarterly

FCF

Interested in knowing about Genmab's free cash flow? The latest report shows it as 1.99B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: DKK

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Genmab shows that the company's current ratio is 5.17, indicating healthy liquidity.

Currency: DKK

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Genmab, the quick ratio is 5.15, indicating that the company can meet its short-term debt obligations.

Currency: DKK

Quarterly

ROE

Want to learn more about the financial health of Genmab? The latest ROE figure is 4.03%, indicating that the company has stable profitability.

Currency: DKK

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Genmab, the total asset return on investment (ROA) is 3.23%.

Currency: DKK

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Genmab's latest financial report to see how their gross margin is doing - currently at 95.07%.

Currency: DKK

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Genmab, the net profit margin is 22.85%, which is a good sign for its profitability.

Currency: DKK

Quarterly

Trending US Stocks